2026. Biomedical perspective on onabotulinumtoxinA: efficacy and clinical management in chronic migraine treatment. Research, Society and Development. 15, 5 (May 2026), e1215551006. DOI:https://doi.org/10.33448/rsd-v15i5.51006.